< Back to previous page
Researcher
Evelien Moorkens
- Disciplines:Biomarker discovery and evaluation, Drug discovery and development, Medicinal products, Pharmaceutics, Pharmacognosy and phytochemistry, Pharmacology, Pharmacotherapy, Toxicology and toxinology, Other pharmaceutical sciences
Affiliations
- Clinical Pharmacology and Pharmacotherapy (Division)
Member
From17 Sep 2015 → 30 Sep 2021
Projects
1 - 1 of 1
- A multifaceted view on market access of biosimilarsFrom17 Sep 2015 → 18 Aug 2020Funding: BOF - Doctoral projects
Publications
1 - 10 of 20
- The Expiry of Humira® Market Exclusivity and the Entry of Adalimumab Biosimilars in Europe: An Overview of Pricing and National Policy Measures(2021)
Authors: Evelien Moorkens, Isabelle Huys, Arnold Vulto
Pages: 1 - 17 - A Look at the History of Biosimilar Adoption: Characteristics of Early and Late Adopters of Infliximab and Etanercept Biosimilars in Subregions of England, Scotland and Wales - A Mixed Methods Study(2021)
Authors: Evelien Moorkens, Arnold Vulto, Steven Simoens, Isabelle Huys
- Learnings from Regional Market Dynamics of Originator and Biosimilar Infliximab and Etanercept in Germany(2020)
Authors: Evelien Moorkens, Arnold Vulto, Isabelle Huys, Steven Simoens
Pages: 1 - 20 - Biosimilars in Oncology – Part II: Considerations about the clinical use of oncology biosimilars(2020)
Authors: Liese Barbier, Evelien Moorkens, Yannick Vandenplas, Arnold Vulto
Pages: 286 - 292 - Biosimilars in oncology - Part I: The principles of biosimilars(2020)
Authors: Evelien Moorkens, Yannick Vandenplas, Liese Barbier, Arnold Vulto
Pages: 280 - 285 - A multifaceted view on market access of biosimilars(2020)
Authors: Evelien Moorkens, Isabelle Huys, Paul Declerck, Arnold Vulto
- Uptake of Biosimilar Infliximab in the UK, France, Japan, and Korea: Budget Savings or Market Expansion Across Countries?(2020)
Authors: Evelien Moorkens, Steven Simoens
Pages: 1 - 12 - Biosimilars in Belgium: a proposal for a more competitive market(2020)
Authors: Evelien Moorkens, Arnold Vulto, Isabelle Huys
Pages: 1 - 12 - An overview of patents on therapeutic monoclonal antibodies in Europe: are they a hurdle to biosimilar market entry?(2020)
Authors: Evelien Moorkens, Arnold Vulto, Isabelle Huys
Pages: 1 - 15 - Economic evaluation of biosimilars for reimbursement purposes – what, when, how?(2020)
Authors: Evelien Moorkens, Isabelle Huys, Arnold Vulto, Steven Simoens
Pages: 1 - 4